| ABT |
Abbott Laboratories |
72%
|
Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), South Africa, South Korea, India, New Zealan… |
| ABT |
Abbott Laboratories |
72%
|
Reciprocal relationship from ABT graph: Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The… |
| BDX |
Becton, Dickinson and Company |
72%
|
Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), South Africa, South Korea, India, New Zealan… |
| BDX |
Becton, Dickinson and Company |
72%
|
Reciprocal relationship from BDX graph: Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The… |
| BSX |
Boston Scientific Corporation |
72%
|
Reciprocal relationship from BSX graph: Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The… |
| BSX |
Boston Scientific Corporation |
72%
|
Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), South Africa, South Korea, India, New Zealan… |
| EW |
Edwards Lifesciences Corporation |
72%
|
Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), South Africa, South Korea, India, New Zealan… |
| EW |
Edwards Lifesciences Corporation |
72%
|
Reciprocal relationship from EW graph: Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The … |
| JNJ |
Johnson & Johnson |
72%
|
Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), South Africa, South Korea, India, New Zealan… |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from MMSI graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our pro… |
| TFX |
Teleflex Incorporated |
72%
|
Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), South Africa, South Korea, India, New Zealan… |
| TFX |
Teleflex Incorporated |
72%
|
Reciprocal relationship from TFX graph: Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The… |
| BIOLIFE-TRANSACTION-SUB-LLC |
BIOLIFE-TRANSACTION-SUB-LLC |
62%
|
. The goodwill consists largely of the synergies expected from combining operations and is expected to be deductible for tax purposes. The pro forma effects to our consolidated results of operations … |
| BIOSPHERE-MEDICAL-INC |
BIOSPHERE-MEDICAL-INC |
62%
|
ecember 31 $ 446,514 $ 16,997 $ 463,511 $ 382,240 $ — $ 382,240 Total accumulated goodwill impairment losses aggregated to $ 8.3 million as of December 31, 2024 and 2023. We did no t ha… |
| BIOTRACE-MEDICAL-INC |
BIOTRACE-MEDICAL-INC |
62%
|
asset purchase and recorded $ 1.5 million of acquired in-process research and development expense associated with the upfront payment and completion of the milestone related to the installation of th… |
| BLUEGRASS-VASCULAR-TECHNOLOGIES-INC |
BLUEGRASS-VASCULAR-TECHNOLOGIES-INC |
62%
|
. We have estimated the weighted average life of the intangible assets acquired from AngioDynamics to be 10.5 years. The goodwill consists largely of the synergies expected from combining operations … |
| CIANNA-MEDICAL-DFINE-INC |
CIANNA-MEDICAL-DFINE-INC |
62%
|
ecember 31 $ 446,514 $ 16,997 $ 463,511 $ 382,240 $ — $ 382,240 Total accumulated goodwill impairment losses aggregated to $ 8.3 million as of December 31, 2024 and 2023. We did no t ha… |
| COOK-MEDICAL-HOLDINGS-LLC |
COOK-MEDICAL-HOLDINGS-LLC |
62%
|
ss, slow moving and obsolete inventories by developing an independent expectation and comparing our independent expectation to the results of the Company’s calculation. ● We tested the mathematical a… |
| ENDOGASTRIC-SOLUTIONS-INC |
ENDOGASTRIC-SOLUTIONS-INC |
62%
|
ss, slow moving and obsolete inventories by developing an independent expectation and comparing our independent expectation to the results of the Company’s calculation. ● We tested the mathematical a… |
| FIBROVEIN-HOLDINGS-LIMITED |
FIBROVEIN-HOLDINGS-LIMITED |
62%
|
. We test goodwill balances for impairment on an annual basis as of July 1 or whenever impairment indicators arise. When impairment indicators are identified, we may elect to perform an optional qual… |
| HEALTH-LINE-INTERNATIONAL-CORPORATION |
HEALTH-LINE-INTERNATIONAL-CORPORATION |
62%
|
onsolidated statements of income, were approximately $ 1.9 million during the year ended December 31, 2025. The purchase price was allocated as follows (in thousands): Assets Acquired … |
| RESTORE-ENDOSYSTEMS-LLC |
RESTORE-ENDOSYSTEMS-LLC |
62%
|
. On April 30, 2022, we acquired the Restore Endosystems Bifurcated Stent System pursuant to the terms of a unit purchase agreement we executed with all of the members of Restore Endosystems LLC. Sub… |
| SCHOLTEN-SURGICAL-INSTRUMENTS-INC |
SCHOLTEN-SURGICAL-INSTRUMENTS-INC |
62%
|
. We have estimated the weighted average life of the intangible assets acquired from EGS to be 10.1 years. The goodwill consists largely of the synergies expected from combining operations and is exp… |
| VIEW-POINT-MEDICAL-INC |
VIEW-POINT-MEDICAL-INC |
62%
|
not be recoverable. Fair value is generally determined based on discounted future cash flow. All our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of th… |
